Browsing Tag

Biologics Manufacturing

384 posts

CDMOs Invest in Biomanufacturing, Cell- & Gene-Therapy Manufacturing
By

By
Biomanufacturing is an active area of investment by CDMOs with several large expansions by Samsung Biologics, Fujifilm Diosynth, Boehringer Ingelheim, and Lonza. Other CDMOs (Catalent, Thermo Fisher, WuXi AppTec, AGC…

Fujifilm To Sell Radiopharm Business; Avantor Investing in Hydration Services
By

By
The latest from CDMOs, CMOs, and suppliers featuring Fujifilm Toyama Chemical, Avantor, Thermo Fisher Scientific, SK pharmteco, BioDuro-Sundia, ten23 health, and others. Chemicals/Chemical API Manufacturing  Fujifilm To Sell Radiopharmaceutical Business…

AGC Biologics Breaks Ground on Facility; Lonza Expands Drug-Product Mfg
By

By
The latest from CDMOs, CMOs, and suppliers featuring AGC Biologics, Lonza, Sartorius, Quotient Sciences, Recipharm, and SAI Life Sciences. Chemicals/Chemical API Manufacturing Quotient Sciences To Invest $8.6 M in Drug-Substance…

Recro Acquires Irisys for $50 M; Curia Investing $35 M in Mfg Expansion
By

By
The latest from CDMOs, CMOs, and suppliers featuring Recro Pharma, Curia, Vectura, Syngene, Xellia, Comar, Schott, and Aptar Pharma. Chemicals/Chemical API Manufacturing Curia To Invest $35 M To Expand Commercial…

CDMO, CMO, Supplier Roundup in Supporting COVID-19 Projects
By

By
The latest from CDMOs/CMOs and suppliers in COVID-19 projects featuring Seppic and SiO2 Materials Science. Biologics Manufacturing Akston, Seppic in Supply Pact for COVID-19 Vaccine AdjuvantAkston Biosciences, a Beverly, Massachusetts-based…

AGC Acquires Former Novartis Mfg Facility; BI, GRAM Expand
By

By
The latest from CDMOs, CMOs, and suppliers featuring AGC Biologics, Boehringer Ingelheim (BI), Grand River Aseptic Manufacturing (GRAM), Evonik, Rentschler Biopharma, Aphena, and others. Chemicals/Chemical API Manufacturing Heraeus Expands Capacity…

TriRx Acquires Elanco Mfg Facility; Metrics, Celanese Expand
By

By
The latest from CDMOs, CMOs, and suppliers featuring TriRx Pharmaceutical Services, Catalent, Metrics Contract Services, Celanese, and Pii.  Biologics Manufacturing Catalent Completes Acquisition of RheinCell Therapeutics Catalent has completed its…

PerkinElmer To Acquire BioLegend for $5.25-Bn; Resilience, Grifols Expand
By

By
The latest from CDMOs, CMOs, and suppliers featuring PerkinElmer, Resilience, Grifols, WuXi Biologics, Catalent, and SCA Pharma. Biologics Manufacturing Resilience To Acquire Cell-Therapy Mfg Facility from bluebird bio Resilience, a…

Cytiva, Pall Investing $1.5 Bn To Expand Life-Science Product Mfg
By

By
Cytiva, the new name of GE Healthcare Life Sciences following Danaher’s $21.4-billion acquisition of GE Healthcare Life Sciences in 2020, and Pall Corporation, a provider of filtration, separation, and purification…

Catalent Plans $100-M Expansion of Italian Facility
By

By
Catalent has announced that it will begin the first phase of a planned $100-million expansion at its facility in Anagni, Italy to add biologics drug-substance manufacturing. The initial phase of…